Literature DB >> 32327948

CoMFA/CoMSIA/HQSAR and Docking Study of the Binding Mode of Selective Cyclooxygenase (COX-2) Inhibitors.

Haifeng Chen1,2, Qiang Li2, Xiaojun Yao1, BoTao Fan1, Shengang Yuan2, A Panaye1, J P Doucet1.   

Abstract

The intermolecular interaction between four types of anti-inflammatory inhibitors (oxazoles, pyrazoles, pyrroles and imidazoles) and COX-2 receptor was studied. The results of docking suggest that they have similar interaction mechanism. The most active compounds of these four types of inhibitors could both form several hydrogen bonds with residues His90, Arg513, Leu352 and Arg120, and develop hydrophobic interaction with residues Phe518, Leu352 and Leu359. This is consistent with the investigation reported by R. G. Kurumbail et al. (Nature. 1996, 384, 644-648). A common 3D-QSAR model could be constructed with these four categories of COX-2 inhibitors using the method of docking- guided conformer selection. The cross-validated q2 values are found as 0.741 and 0.632 for CoMFA and CoMSIA respectively. And the non-cross-validated r2 values are 0.887 and 0.885. 54 inhibitors constitute the test set used to validate the model. The results show that this model possesses good predictive ability for diverse COX-2 inhibitors. Furthermore, a HQSAR model was used to evaluate the influence of substituents on anti-inflammatory activity. Compared with the results of previous works, our model possesses significantly better prediction ability. It could help us to well understand the interaction mechanism between inhibitors and COX-2 receptor, and to make quantitative prediction of their inhibitory activities.
Copyright © 2004 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  3D‐QSAR; Cyclooxygenase (COX‐2) Inhibitors; Docking; HQSAR

Year:  2004        PMID: 32327948      PMCID: PMC7168538          DOI: 10.1002/qsar.200330844

Source DB:  PubMed          Journal:  QSAR Comb Sci        ISSN: 1611-020X


  23 in total

1.  Comparative molecular similarity index analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries.

Authors:  G Klebe; U Abraham
Journal:  J Comput Aided Mol Des       Date:  1999-01       Impact factor: 3.686

2.  Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis.

Authors:  P Chavatte; S Yous; C Marot; N Baurin; D Lesieur
Journal:  J Med Chem       Date:  2001-09-27       Impact factor: 7.446

Review 3.  Cyclooxygenase (COX) inhibitors: a comparative QSAR study.

Authors:  Rajni Garg; Alka Kurup; Suresh Babu Mekapati; Corwin Hansch
Journal:  Chem Rev       Date:  2003-03       Impact factor: 60.622

4.  Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa.

Authors:  M Böhm; J St rzebecher; G Klebe
Journal:  J Med Chem       Date:  1999-02-11       Impact factor: 7.446

Review 5.  Multivariate data analysis and experimental design in biomedical research.

Authors:  L Ståhle; S Wold
Journal:  Prog Med Chem       Date:  1988

6.  1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2.

Authors:  I K Khanna; R M Weier; Y Yu; P W Collins; J M Miyashiro; C M Koboldt; A W Veenhuizen; J L Currie; K Seibert; P C Isakson
Journal:  J Med Chem       Date:  1997-05-23       Impact factor: 7.446

7.  Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.

Authors:  R G Kurumbail; A M Stevens; J K Gierse; J J McDonald; R A Stegeman; J Y Pak; D Gildehaus; J M Miyashiro; T D Penning; K Seibert; P C Isakson; W C Stallings
Journal:  Nature       Date:  1996 Dec 19-26       Impact factor: 49.962

8.  Computer-aided design of selective COX-2 inhibitors: comparative molecular field analysis, comparative molecular similarity indices analysis, and docking studies of some 1,2-diarylimidazole derivatives.

Authors:  G R Desiraju; B Gopalakrishnan; R K R Jetti; A Nagaraju; D Raveendra; J A R P Sarma; M E Sobhia; R Thilagavathi
Journal:  J Med Chem       Date:  2002-10-24       Impact factor: 7.446

9.  Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents.

Authors:  I K Khanna; Y Yu; R M Huff; R M Weier; X Xu; F J Koszyk; P W Collins; J N Cogburn; P C Isakson; C M Koboldt; J L Masferrer; W E Perkins; K Seibert; A W Veenhuizen; J Yuan; D C Yang; Y Y Zhang
Journal:  J Med Chem       Date:  2000-08-10       Impact factor: 7.446

10.  4-(4-cycloalkyl/aryl-oxazol-5-yl)benzenesulfonamides as selective cyclooxygenase-2 inhibitors: enhancement of the selectivity by introduction of a fluorine atom and identification of a potent, highly selective, and orally active COX-2 inhibitor JTE-522(1).

Authors:  Hiromasa Hashimoto; Katsuaki Imamura; Jun-ichi Haruta; Korekiyo Wakitani
Journal:  J Med Chem       Date:  2002-03-28       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.